Review
Copyright ©The Author(s) 2015.
World J Ophthalmol. Feb 12, 2015; 5(1): 1-15
Published online Feb 12, 2015. doi: 10.5318/wjo.v5.i1.1
Table 1 Staging for severity of cicatricial conjunctivitis
Staging for severity of cicatricial conjunctivitis
Foster Staging[7]
ISubepithelial fibrosis, positive rose-bengal staining in conjunctiva, conjunctival “shrinkage” from abnormal connective tissue due to small white striae that form around the superficial vessels in substantia propria
IIMarked foreshortening of inferior conjunctiva described by (1) 0%-25%; (2) 25%-50%; (3) 50%-75%; and (4) 75%-100%
IIICorneal neovascularization, trichiasis, dystichiasis, keratopathy, subepithelial bands of connective tissue resulting in symblepharon (conjunctival adhesions) formation that is described by (1) 0%-25%; (2) 25%-50%; (3) 50%-75%; and (4) 75%-100%
IVSevere sicca syndrome, keratinization, ankyloblepharon
Mondino Staging[134]
I0%-25% loss of inferior conjunctival fornix depth
II25%-50% loss of inferior conjunctival fornix depth
III50%-75% loss of inferior conjunctival fornix depth
IV75%-100% loss of inferior conjunctival fornix depth
Table 2 Conditions associated with cicatricial conjunctivitis
Trauma
Physical trauma
Chemical burn
Thermal burn
Radiation burn
Infection
Trachoma
Membranous conjunctivitis
Allergic
Chronic atopic keratoconjunctivitis
Mucocutaneous disease
Erythema multiforme
Stevens-Johnson Syndrome
Toxic epidermal necrolysis
Immunobullous disorders
Mucous membrane pemphigoid
Bullous pemphigoid
Pemphigus vulgaris
Paraneoplastic pemphigus
Lichen planus
Dermatitis herpetiformis
Systemic lupus erythematosus
Systemic disorders
Rosacea
Sjogren's syndrome
Graft-vs-host disease
Sarcoidosis
Ectodermal dysplasia
Erythroderma ichthyosiform congenital
Drug-induced
Systemic
Topical
Table 3 Diagnostic criteria for paraneoplastic pemphigus
Diagnostic criteria for paraneoplastic pemphigus
Anhalt et al[94]
Camisa et al[95]
Painful mucosal and polymorphous skin erosions that involves the trunk, extremities, palms, and soles of a patient with a neoplasm Histological changes including intraepidermal acantholysis, keratinocyte necrosis, and vacuolar interface dermatitis) Direct immunofluorescence findings of IgG and complement localized to the intercellular regions of the epithelium in a linear or granular fashion at the basement membrane zone Circulating autoantibodies that bind to stratified squamous epithelium as well as simple, columnar, and transitional epithelium Immunoprecipitation studies that demonstrate the presence of autoantibodies directed against a complex of five proteins of 250, 230, 210, 190, and 170 kDaMajor criteria Polymorphous mucocutaneous eruption Concurrent internal neoplasia Specific serum immunoprecipitation pattern Minor criteria Histology demonstrating acantholysis Direct immunofluorescence demonstrating intercellular and basement membrane staining Indirect immunofluorescence staining with rat murine epithelium Diagnosis: All three major or two major and two minor required to diagnosis paraneoplastic pemphigus
Table 4 Overview of mucous membrane pemphigoid and pseudopemphigoid as caused by the pemphigus disease
MMPPseudopemphigoid
PNPOPV
LocationSubepidermalIntraepidermalIntraepidermal
DIFIgG/IgA/IgM/C3IgG/C3IgG/C3
IIF on salt-split skinDermal, epidermal, or combined depending on antigenNot applicableNot applicable
IEM: ultrastructural location of antigenLamina lucidaHemidesmosomesDesmosomes
Lamina densaDesmosomal plaques
Sublamina densa (anchoring fibrils)Lamina lucida
Immunoblot: determination of antigenBullous pemphigoid antigen 1 (Bullous Pemphigoid 230) Bullous pemphigoid antigen 2 (Bullous Pemphigoid 180, type XVII collagen) Type VII collagen (290 kDa) Laminin332, epiligrin, or laminin 5 α3β3γ2 (165, 145, 140, 105 kDa) Laminin 6 (α3) Integrin beta 4 45 kDa epithelial protein 130 kDa epithelial protein 140 kDa epithelial protein 205 kDa epithelial protein 168 kDa epithelial protein Uncein LAD-1 (97/120 kDa)Plakin protein family: Desmoplakin I (250 kDa) Bullous pemphigoid antigen 1 (230 kDa) Desmoplakin II and envoplakin (210 kDa) Periplakin (190 kDa) Plectin (500 kDa) Desmocollin 2 (105 kDa) Desmocollin 3 α2-macroglobulin-like-1 (A2LM1, 170 kDa) Desmoglein 1 (160 kDa) Desmoglein 3 (130 kDa)Desmoglein 1 (160 kDa) Desmoglein 3 (130 kDa)
Increased malignancyYes - solid malignancies (laminin 332 subtype)Yes - lymphoproliferative malignancies--